Practice Alert

USPSTF update on sexually transmitted infections

Author and Disclosure Information

 

References


Although hepatitis C virus (HCV) is transmitted mainly through intravenous drug use, it can also be transmitted sexually. The Task Force recommends screening for HCV in all adults ages 18 to 79 years.13

Vaccination. Two STIs can be prevented by immunizations: HPV and HBV. The current recommendations by the Advisory Committee on Immunization Practices (ACIP) are to vaccinate all infants with HBV vaccine and all unvaccinated children and adolescents through age 18.14 Unvaccinated adults who are at risk for HBV infection, including those at risk through sexual practices, should also be vaccinated.14

ACIP recommends routine HPV vaccination at age 11 or 12 years, but it can be started as early as 9 years.15 Catch-up vaccination is recommended for males and females through age 26 years.15 The vaccine is approved for use in individuals ages 27 through 45 years, but ACIP has not recommended it for routine use in this age group, and has instead recommended shared clinical decision-making to evaluate whether there is potential individual benefit from the vaccine.15

Public health implications

All STIs are reportable to local or state health departments. This is important for tracking community infection trends and, if resources are available, for contact notification and testing. In most jurisdictions, local health department resources are limited and contact tracing may be restricted to syphilis and HIV infections. When this is the case, it is especially important to instruct patients in whom STIs have been detected to notify their recent sex partners and advise them to be tested or preventively treated.

Recurring counseling is preferrable, but a single session lasting about 30 minutes can also be effective.

Expedited partner therapy (EPT)—providing treatment for exposed sexual contacts without a clinical encounter—is allowed in some states and is a tool that can prevent re-infection in the treated patient and suppress spread in the community. This is most useful for partners of those with gonorrhea, chlamydia, or trichomonas. The CDC has published guidance on how to implement EPT in a clinical setting if state law allows it.16

Pages

Recommended Reading

COVID-19 and risk of clotting: ‘Be proactive about prevention’
MDedge Family Medicine
Joint guidelines favor antibody testing for certain Lyme disease manifestations
MDedge Family Medicine
New child COVID-19 cases down in last weekly count
MDedge Family Medicine
Children and school during the pandemic: What’s the answer?
MDedge Family Medicine
C. difficile control could require integrated approach
MDedge Family Medicine
Three genes could predict congenital Zika infection susceptibility
MDedge Family Medicine
A 70-year-old presented with a 3-week history of asymptomatic violaceous papules on his feet
MDedge Family Medicine
Can a health care worker refuse the COVID-19 vaccine?
MDedge Family Medicine
COVID-19 vaccines: Preparing for patient questions
MDedge Family Medicine
Home visits: A practical approach
MDedge Family Medicine